Related Experiment Video
Updated: Jun 7, 2026

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
The changing epidemiology of congenital heart disease
Teun van der Bom1, A Carla Zomer, Aeilko H Zwinderman
1Department of Cardiology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Insights
Congenital heart disease (CHD) affects newborns, with survivors facing late complications like heart failure. Accurate prevalence data is crucial for effective long-term care planning for this growing population.
Area of Science:
- Cardiology
- Pediatrics
- Genetics
Background:
- Congenital heart disease (CHD) is the most common birth defect.
- Medical advances allow most CHD patients to survive into adulthood.
- Adult survivors face significant late complications, including heart failure and arrhythmias.
Purpose of the Study:
- To provide a comprehensive overview of congenital heart disease.
- To review the etiology, prevalence, mortality, and complications of CHD.
- To highlight challenges in managing the growing CHD population.
Main Methods:
- Review of existing literature on congenital heart disease.
- Analysis of birth prevalence and survival rate data.
- Examination of factors influencing CHD prevalence and outcomes.
Main Results:
- Estimates of CHD birth prevalence vary significantly.
- Accurate current prevalence data is lacking, complicating care planning.
- Improved survival has led to an increasing adult CHD population with complex needs.
Conclusions:
- Effective management of congenital heart disease requires better prevalence data.
- Long-term follow-up and specialized care are essential for adult CHD patients.
- Further research into etiology may inform future preventative strategies.
Abstract:
Congenital heart disease is the most common congenital disorder in newborns. Advances in cardiovascular medicine and surgery have enabled most patients to reach adulthood. Unfortunately, prolonged survival has been achieved at a cost, as many patients suffer late complications, of which heart failure and arrhythmias are the most prominent. Accordingly, these patients need frequent follow-up by physicians with specific knowledge in the field of congenital heart disease. However, planning of care for this population is difficult, because the number of patients currently living with congenital heart disease is difficult to measure. Birth prevalence estimates vary widely according to different studies, and survival rates have not been well recorded. Consequently, the prevalence of congenital heart disease is unclear, with estimates exceeding the number of patients currently seen in cardiology clinics. New developments continue to influence the size of the population of patients with congenital heart disease. Prenatal screening has led to increased rates of termination of pregnancy. Improved management of complications has changed the time and mode of death caused by congenital heart disease. Several genetic and environmental factors have been shown to be involved in the etiology of congenital heart disease, although this knowledge has not yet led to the implementation of preventative measures. In this Review, we give an overview of the etiology, birth prevalence, current prevalence, mortality, and complications of congenital heart disease.
Related Concept Videos
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology

